Kevin D. Foust

Department of Neuroscience, Ohio State University

Research Area

Biography

Kevin D. Foust has not added Biography.
If you are Kevin D. Foust and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 78	2014

Other Publications

Article	Year
Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 16412695	2006
Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons. Human gene therapy\| PubMed ID: 18052722	2008
Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts ... Human gene therapy\| PubMed ID: 18072858	2008
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nature biotechnology\| PubMed ID: 19098898	2009
Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19277011	2009
AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS. Current gene therapy\| PubMed ID: 19860657	2009
Over the barrier and through the blood: to CNS delivery we go. Cell cycle (Georgetown, Tex.)\| PubMed ID: 19949299	2009
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nature biotechnology\| PubMed ID: 20190738	2010
Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Human molecular genetics\| PubMed ID: 20639395	2010
A role for glia in the progression of Rett's syndrome. Nature\| PubMed ID: 21716289	2011
Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 21811247	2011
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nature biotechnology\| PubMed ID: 21832997	2011
Recombinant AAV delivery to the central nervous system. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 22034030	2011
A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Human molecular genetics\| PubMed ID: 22186025	2012
Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Human gene therapy\| PubMed ID: 22201473	2012
Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Human gene therapy\| PubMed ID: 22838844	2012
Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 23966684	2013
Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 24008656	2013
Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron\| PubMed ID: 24607225	2014
Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA - a dose response study in mice and nonhuman primates. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 25358252	2014
Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice. Frontiers in molecular neuroscience\| PubMed ID: 25360081	2014